Brent Sloten, DO
Dermatology · Phoenix, AZNPI 1073585402
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $11,194 of the $16,059 with a category attached, or 69.7%. Galderma Laboratories, L.p. accounts for 76.2% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $11,052 and has fallen 98.9% since, to $120 in 2025.
Across 252 payments — averaging $63.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$12K
- AbbVie$835
- Incyte Corporation$711
- Johnson & Johnson$456
- Sun Pharmaceutical Industries Inc.$409
- Arcutis Biotherapeutics, Inc.$227
- plus $1K from 14 others
What the payments were for
- Speaking & faculty fees$11,19470%
- Travel & lodging$4253%
- Food & beverage$4,35727%
- Education$831%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 42 | $12,245 |
| AbbVie(2 entities) | 47 | $835 |
| Incyte Corporation | 29 | $711 |
| Johnson & Johnson | 26 | $456 |
| Sun Pharmaceutical Industries Inc. | 38 | $409 |
| Arcutis Biotherapeutics, Inc. | 6 | $227 |
| Pfizer | 21 | $201 |
| Sanofi | 5 | $196 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| Regeneron Healthcare Solutions, Inc. | 1 | $120 |
| Novartis | 7 | $118 |
| Dermira, Inc. | 6 | $104 |
| Lilly USA, LLC | 5 | $83 |
| LEO Pharma Inc. | 4 | $53 |
| Mayne Pharma Commercial LLC | 5 | $44 |
| Almirall LLC | 2 | $40 |
| Prugen, Inc. Pharmaceuticals | 3 | $32 |
| Dermavant Sciences, Inc. | 2 | $31 |
| EPI Health, LLC | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,059 in reported general payments places this provider in the 85th percentile of 305 dermatology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 31 | $422 |
| Mupirocin | 33 | $340 |
| Ketoconazole | 19 | $317 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Phoenix
- Lindsay AckermanPhoenix$1.6M
- Nathalie ZeitouniPhoenix$584K
- Carsten HamannPhoenix$364K
- Michael CrandallPhoenix$153K
- Sadra JazayeriPhoenix$115K
- Cynthia PricePhoenix$76K
- William KoPhoenix$66K
- Dathan HamannPhoenix$56K
- Peter SigalPhoenix$30K
- Xuan NguyenPhoenix$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.